Artistic productivity and creative thinking in Parkinson's disease

Background and purpose:  Creative drive and enhanced artistic‐like production may emerge in patients with Parkinson’s disease (PD) during dopaminergic therapy. However, it has not been described to date whether this artistic‐like production results from dopaminergic drugs triggering innate skills or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of neurology 2012-03, Vol.19 (3), p.468-472
Hauptverfasser: Canesi, M., Rusconi, M. L., Isaias, I. U., Pezzoli, G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and purpose:  Creative drive and enhanced artistic‐like production may emerge in patients with Parkinson’s disease (PD) during dopaminergic therapy. However, it has not been described to date whether this artistic‐like production results from dopaminergic drugs triggering innate skills or it could be considered as a repeated behavior possibly associated with impulse control disorders (ICDs). Methods:  We investigated creative drive in a cohort of cognitively preserved patients with PD by means of the Torrance Test of Creative Thinking (TTCT). We also investigated a putative association between creative drive and ICDs in 36 PD patients with (PD‐c) or without (PD‐nc) increased artistic‐like production and 36 healthy controls (HC). We considered artistic‐like productivity to be enhanced if patients reported working on any form of art more than 2 h per day after the introduction of dopaminergic treatment. The TTCT, the Barratt Impulsiveness Scale (BIS‐11A), the Minnesota Impulsive Disorders Interview (MIDI), and the Punding Rating Scale were applied. Results:  Mean TTCT score of PD‐c was found to be similar to HC (169.4 ± 51.6 vs. 170.2 ± 69.7, respectively), and both PD‐c and HC had significantly higher TTCT scores than patients with PD‐nc (125.4 ± 46.1 P 
ISSN:1351-5101
1468-1331
DOI:10.1111/j.1468-1331.2011.03546.x